ADRB3 and peripheral arterial disease: The agonist stimulation of β3AR counteracts endothelial oxidative stress and limb ischemia by re-balancing redox conditions, increasing angiogenesis and facilitating NO-induced vasodilation, making it an interesting target for PAD and hypoxic wound healing [58].